HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
SangStat's SangCya Oral Solution -- Cyclosporine -- Approved in Germany; German Cyclosporine Oral Solution Market Largest in Europe.
-
Business Wire; Apr 10, 2000; 700+ Words
...worldwide market. SangStat intends to...globally, SangCya(R) (Cyclosporine Oral Solution, USP (MODIFIED...solution. SangStat's The Transplant...statements reflect SangStat's current views...acceptance of SangCya Oral Solution. These factors...
-
-
SangStat Launches SangCya Oral Solution in the UK.
-
Business Wire; Apr 14, 1999; 700+ Words
...TM) Oral Solution in the United...approval of SangCya(TM) for...offer SangCya oral solution...Bienaime, SangStat's President...approval for SangCya(TM) (Cyclosporine Oral Solution, USP (MODIFIED...December 1998. SangStat is ...
-
-
SangStat recalls all lots of SangCya oral solution after telling FDA it's not bioequivalent to Novartis' Neoral.
-
Transplant News; Jul 14, 2000; 700+ Words
...July 10 that the SangStat Medical Corporation...recall all lots of SangCya oral solution because of clinical...Novartis AG's Neoral oral solution when...Both the FDA and SangStat urged transplant...currently taking SangCya (cyclosporine...
-
-
SangStat's SangCya oral solution approved in Germany.(Brief Article)
-
Transplant News; Apr 28, 2000; 525 Words
The SangStat Medical Corporation, Fremont, CA, announced SangCya Oral Solution has been approved in Germany...Procedure, the company reports. SangStat says it intends to launch SangCya Oral Solution in Germany this...
-
-
SangStat Announces State Formulary Wins for SangCya Oral Solution.
-
Business Wire; Jun 11, 1999; 700+ Words
...approval for SangCya oral solution in October...December 1998. SangCya was also approved...28, 1999. SangStat is based in...SangStat's European base...statements reflect SangStat's current views...acceptance of SangCya oral solution. ...
-
-
SangStat receives first European approval for its generic oral solution cyclosporine, SangCya.
-
Transplant News; Feb 14, 1999; 660 Words
SangStat Medical Corporation, Menlo...marketing approval to SangCya Oral Solution (cyclosporine) for prevention...Characteristics within 90 days. SangStat says it expects approval...second half of 1999.] SangCya's transplant-related indications...
-
-
Novartis Fails to Get SangCya UK Approval Revoked; British Court Rules in Favor of Medicines Control Agency -MCA- and SangStat.
-
Business Wire; Mar 31, 2000; 700+ Words
...March 31, 2000 SangStat, The Transplant...authorization of SangStat UK's SangCya Oral Solution (cyclosporine...52 countries; SangCya (Cyclosporine Oral Solution, USP [MODIFIED...storage solution. SangStat's The Transplant...
-
-
U.S. FDA Clears SangStat's Cyclosporine, SangCya for Treatment of Solid Organ Transplants; First Competitor Since 1983 to Novartis' Leading Product May Save Average Patient $1,200 Per Year.
-
Business Wire; Nov 3, 1998; 700+ Words
...1998--SangStat, The Transplant...that the U.S. Food and...approval to SangCya(TM) (Cyclosporine Oral Solution, USP (MODIFIED...Neoral(R) oral solution. SangCya ("sang-see-ah") is SangStat's patented...proprietary to SangStat. It has...signifying ...
-
-
SangStat Launches New Cyclosporine, SangCya in the US; Company Ships Product Less Than Three Weeks After FDA Approval.
-
Business Wire; Nov 19, 1998; 700+ Words
...SangCya(tm) (Cyclosporine Oral Solution, USP (MODIFIED), 100 mg/mL). SangCya was approved for marketing...rating versus Neoral(R) oral solution. SangCya ("sang-see-ah") is SangStat's patented formulation of...
-
-
Courts in US, UK rule in favor of SangStat over Novartis in separate cases involving SangCya.
-
Transplant News; Apr 10, 2000; 700+ Words
The SangStat Medical Corporation...authorization of SangStat UK's SangCya Organ Solution revoked. The...in granting the SangCya Oral Solution marketing...Novartis to pay MCA's costs incurred...since April 1999. SangStat UK also filed...
-
-
SangStat Receives Second Cyclosporine US Patent; Covers Newly FDA Approved SangCya.
-
Business Wire; Nov 3, 1998; 700+ Words
...1998--SangStat, The Transplant...827,822, SangStat's second patent...cyclosporine. SangCya(TM) (Cyclosporine Oral Solution, USP (MODIFIED...company's first product...Neoral(R) oral solution...the time of SangCya market approval...and CEO of ...
-
-
SangStat Announces Celsior 510k Clearance by the FDA; Celsior is the First Cold Storage Solution for Donor Hearts Indicated for Use in the US.
-
Business Wire; Aug 11, 1999; 700+ Words
...cold storage solution(s) used by...the other solutions tested. The...other organs. SangStat, The Transplant...Company(R) SangStat is a specialty...SangStat launched SangCya (Cyclosporine Oral Solution, USP (MODIFIED...SangStat's European base...
-
-
SangStat Will Continue to Offer Lower Cost Therapy to Transplant Recipients and Fight Monopolistic Actions; Novartis Files Patent Infringement Suit in the United Kingdom.
-
Business Wire; Jul 22, 1999; 700+ Words
...covering SangStat's proprietary...including SangCya(TM) (Cyclosporine Oral Solution, USP (MODIFIED...filed against SangStat by Novartis...respect to SangCya oral solution in the US...resolved in SangStat's favor or that...
-
-
SangStat Files for Approval of Cyclosporine Capsule in Europe Ahead of Schedule.
-
Business Wire; Mar 31, 1999; 700+ Words
...March 31, 1999--SangStat, The Transplant...authorization for SangStat's SangCya capsules for prevention...of SangCya(tm) Oral Solution for prevention of...market acceptance of SangStat's SangCya oral solution, Thymoglobulin...
-
-
SANGSTAT WILL CONTINUE TO OFFER CYCLOSPORINE THERAPY.(Novartis files a patent infringement lawsuit)
-
Worldwide Biotech; Sep 1, 1999; 700+ Words
...issued to SangStat two separate...covering SangStat's proprietary...including SangCya(TM) (Cyclosporine Oral Solution, USP (MODIFIED...SangCya oral solution On October...rating to SangStat's SangCya oral solution for...
-
-
Novartis Fails to Derail FDA-Mandated Neoral Cyclosporine Labeling Change; SangStat and the FDA Successfully Defeat Novartis' Request to Postpone Its Neoral Label Change.
-
Business Wire; Dec 7, 1999; 700+ Words
...includes SangStat's SangCya(R) (Cyclosporine Oral Solution, USP (MODIFIED...SangCya oral solution On October...rating to SangStat's SangCya oral solution...cold storage solution in September...countries. SangCya ...
-
-
US Court Rejects Novartis' Attempt to Separate Anti-Trust and Patent Infringement Lawsuits; SangStat Prevails in Opposing Novartis' Motion.
-
Business Wire; Apr 5, 2000; 700+ Words
...globally; SangCya(R) [Cyclosporine Oral Solution, USP (MODIFIED...solution. SangStat's The Transplant...statements reflect SangStat's current views...filed against SangStat by Novartis...respect to SangCya Oral Solution in the United...
-
-
Sangstat Medical Corporation Reports Second Quarter Results.
-
Business Wire; Aug 11, 1999; 700+ Words
...from IMTIX-SangStat (SangStat's European...sales of SangCya(R) (Cyclosporine Oral Solution, USP (MODIFIED...Cyclosporine Oral Solution, USP (MODIFIED...the US. SangStat now markets...countries. SangCya Oral Solution...SangStat's ...
-
-
Abbott Laboratories Completes Equity Investment in SangStat.
-
Business Wire; Aug 10, 1999; 700+ Words
...to SangCya oral solution, and the lawsuit...outcomes, see SangStat's 1998 Form 10...and the Company's filings on Form...information for SangCya oral solution and Thymoglobulin and copies of SangStat's latest press releases...
-
-
Novartis, SangStat reach global settlement agreement over patent infringement suits filed by Novartis.(Brief Article)
-
Transplant News; Aug 12, 2000; 700+ Words
...was filed by Novartis against SangStat on February 11, 1999, in the...suit, Novartis claimed that SangStat's oral solution, SangCya, employs a cyclosporine technology...willing to publicly disclose, SangStat acknowledged that the Novartis...
|
|